These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14574669)

  • 1. Use of pharmaceutical promotility agents in the treatment of body packers.
    Traub SJ; Su M; Hoffman RS; Nelson LS
    Am J Emerg Med; 2003 Oct; 21(6):511-2. PubMed ID: 14574669
    [No Abstract]   [Full Text] [Related]  

  • 2. Promotility agents in the intensive care unit.
    Zaloga GP; Marik P
    Crit Care Med; 2000 Jul; 28(7):2657-9. PubMed ID: 10921616
    [No Abstract]   [Full Text] [Related]  

  • 3. Prokinetic agents in critical care.
    Doherty WL; Winter B
    Crit Care; 2003 Jun; 7(3):206-8. PubMed ID: 12793865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Promotility drugs use in critical care: indications and limits?].
    Libert N; De Rudnicki S; Cirodde A; Janvier F; Leclerc T; Borne M; Brinquin L
    Ann Fr Anesth Reanim; 2009 Nov; 28(11):962-75. PubMed ID: 19910155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotility agents for the treatment of ileus in adult surgical patients: A practice management guideline from the Eastern Association for the Surgery of Trauma.
    Bugaev N; Bhattacharya B; Chiu WC; Como JJ; Cripps MW; Ferrada P; Gelbard RB; Gondek S; Kasotakis G; Kim D; Mentzer C; Robinson BRH; Salcedo ES; Yeh DD
    J Trauma Acute Care Surg; 2019 Oct; 87(4):922-934. PubMed ID: 31136527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence.
    Booth CM; Heyland DK; Paterson WG
    Crit Care Med; 2002 Jul; 30(7):1429-35. PubMed ID: 12130957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks.
    Hawkyard CV; Koerner RJ
    J Antimicrob Chemother; 2007 Mar; 59(3):347-58. PubMed ID: 17289772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study.
    MacLaren R; Kuhl DA; Gervasio JM; Brown RO; Dickerson RN; Livingston TN; Swift K; Headley S; Kudsk KA; Lima JJ
    Crit Care Med; 2000 Feb; 28(2):438-44. PubMed ID: 10708180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prokinetics in gastroparesis.
    Acosta A; Camilleri M
    Gastroenterol Clin North Am; 2015 Mar; 44(1):97-111. PubMed ID: 25667026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of erythromycin and metoclopramide in treatment of feeding intolerance of critically ill patients in intensive care unit].
    Lu NF; Zheng RQ; Lin H; Yang DG; Chen QH; Shao J; Yu JQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Jan; 22(1):36-9. PubMed ID: 20092709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on: The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks.
    Deane A; Young R
    J Antimicrob Chemother; 2008 Jan; 61(1):227; author reply 227-8. PubMed ID: 17981832
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis.
    Erbas T; Varoglu E; Erbas B; Tastekin G; Akalin S
    Diabetes Care; 1993 Nov; 16(11):1511-4. PubMed ID: 8299441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric emptying in the critically ill.
    Schuster-Bruce M
    Crit Care Med; 2001 Jun; 29(6):1293-4. PubMed ID: 11395631
    [No Abstract]   [Full Text] [Related]  

  • 14. Pediatric emergency medicine: legal briefs.
    Selbst SM
    Pediatr Emerg Care; 2005 Sep; 21(9):633-6. PubMed ID: 16160675
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of hyperinsulinaemia on erythromycin-induced gallbladder and gastric motility in normal subjects.
    Cordoni MC; Distrutti E; Vermigli C; Marino C; Bottini P; Bosso R; Scionti L
    Diabetes Nutr Metab; 2004 Feb; 17(1):72-5. PubMed ID: 15163131
    [No Abstract]   [Full Text] [Related]  

  • 16. Asymptomatic body packers should be treated conservatively.
    Glovinski PV; Lauritsen ML; Bay-Nielsen M; Brandstrup B; Bisgaard T
    Dan Med J; 2013 Nov; 60(11):A4723. PubMed ID: 24192240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motility disorders in the ICU: recent therapeutic options and clinical practice.
    Röhm KD; Boldt J; Piper SN
    Curr Opin Clin Nutr Metab Care; 2009 Mar; 12(2):161-7. PubMed ID: 19202387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromycin as a prokinetic agent.
    Kaul A
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):13-5. PubMed ID: 11753157
    [No Abstract]   [Full Text] [Related]  

  • 19. The outcome of drug smuggling by 'body packers'--the British experience.
    Bulstrode N; Banks F; Shrotria S
    Ann R Coll Surg Engl; 2002 Jan; 84(1):35-8. PubMed ID: 11890624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How should we use prokinetic drugs in patients who are intolerant to enteral feeding?
    Asai T
    Crit Care Med; 2007 Feb; 35(2):650-1. PubMed ID: 17251716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.